Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 571

1.

Continuity of care and its effect on readmissions for COPD patients: A comparative study of Norway and Germany.

Swanson JO, Vogt V, Sundmacher L, Hagen TP, Moger TA.

Health Policy. 2018 May 26. pii: S0168-8510(18)30162-3. doi: 10.1016/j.healthpol.2018.05.013. [Epub ahead of print] Review.

PMID:
29933893
2.

Which patients receive surgery in for-profit and non-profit hospitals in a universal health system? An explorative register-based study in Norway.

Holom GH, Alexandersen N, Goldhaber-Fiebert JD, Hagen TP.

BMJ Open. 2018 Jun 9;8(6):e019780. doi: 10.1136/bmjopen-2017-019780.

3.

Characterisation of cellular effects of Burkholderia pseudomallei Cycle inhibiting factor (Cif).

Ng MY, Gan YH, Hagen T.

Biol Open. 2018 May 30. pii: bio.028225. doi: 10.1242/bio.028225. [Epub ahead of print]

4.

The identification of inhibitory compounds of Rickettsia prowazekii methionine aminopeptidase for antibacterial applications.

Helgren TR, Seven ES, Chen C, Edwards TE, Staker BL, Abendroth J, Myler PJ, Horn JR, Hagen TJ.

Bioorg Med Chem Lett. 2018 May 1;28(8):1376-1380. doi: 10.1016/j.bmcl.2018.03.002. Epub 2018 Mar 15.

PMID:
29551481
5.

Evaluation of a Placement Coaching Program for Recipients of Disability Insurance Benefits in Switzerland.

Hagen T.

J Occup Rehabil. 2018 Mar 9. doi: 10.1007/s10926-018-9766-x. [Epub ahead of print]

PMID:
29524032
6.

(Z)-4-Chloro-N-{3-[(4-chlorophenyl)sulfonyl]-2,3-dihydrobenzo[d]thiazol-2-ylidene}benzene-sulfonamide.

Watkins SM, Hagen TJ, Perkins TS, Zheng C.

IUCrdata. 2017;2. pii: x170865. doi: 10.1107/S2414314617008653. Epub 2017 Jun 20.

7.
8.

Metabolic characteristics of Appalachian children.

Gravelle BL, Hagen TW 2nd.

Clin Nutr ESPEN. 2017 Dec;22:36-42. doi: 10.1016/j.clnesp.2017.09.002. Epub 2017 Oct 3.

PMID:
29415832
9.

Dronedarone-Induced Cardiac Mitochondrial Dysfunction and Its Mitigation by Epoxyeicosatrienoic Acids.

Karkhanis A, Leow JWH, Hagen T, Chan ECY.

Toxicol Sci. 2018 May 1;163(1):79-91. doi: 10.1093/toxsci/kfy011.

PMID:
29385569
10.

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles.

Seynhaeve ALB, Ten Hagen TLM.

J Vis Exp. 2017 Nov 1;(129). doi: 10.3791/55405.

11.

Animals Do Not Induce or Reduce Attentional Blinking, But They Are Reported More Accurately in a Rapid Serial Visual Presentation Task.

Hagen T, Laeng B.

Iperception. 2017 Oct 16;8(5):2041669517735542. doi: 10.1177/2041669517735542. eCollection 2017 Sep-Oct.

12.

The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.

Halliday GC, Junckerstorff RC, Bentel JM, Miles A, Jones DTW, Hovestadt V, Capper D, Endersby R, Cole CH, van Hagen T, Gottardo NG.

J Clin Neurosci. 2018 Jan;47:163-167. doi: 10.1016/j.jocn.2017.09.013. Epub 2017 Oct 6.

13.

Planning future care services: Analyses of investments in Norwegian municipalities.

Hagen TP, Tingvold L.

Scand J Public Health. 2018 Jun;46(4):495-502. doi: 10.1177/1403494817730996. Epub 2017 Sep 15.

PMID:
28914585
15.

What modulates animal longevity? Fast and slow aging in bivalves as a model for the study of lifespan.

Blier PU, Abele D, Munro D, Degletagne C, Rodriguez E, Hagen T.

Semin Cell Dev Biol. 2017 Oct;70:130-140. doi: 10.1016/j.semcdb.2017.07.046. Epub 2017 Aug 1. Review.

PMID:
28778411
16.

Demonstration of AutoDock as an Educational Tool for Drug Discovery.

Helgren TR, Hagen TJ.

J Chem Educ. 2017 Mar 14;94(3):345-349. doi: 10.1021/acs.jchemed.6b00555. Epub 2017 Feb 13.

17.

Experimental velocity study of non-Boussinesq Rayleigh-Bénard convection.

Valori V, Elsinga G, Rohde M, Tummers M, Westerweel J, van der Hagen T.

Phys Rev E. 2017 May;95(5-1):053113. doi: 10.1103/PhysRevE.95.053113. Epub 2017 May 25.

PMID:
28618524
18.

Adherence to local antimicrobial guidelines for initial treatment of community-acquired infections.

Hagen TL, Hertz MA, Uhrin GB, Dalager-Pedersen M, Schønheyder HC, Nielsen H.

Dan Med J. 2017 Jun;64(6). pii: A5381.

PMID:
28566116
19.

Outsourcing day surgery to private for-profit hospitals: the price effects of competitive tendering.

Hagen TP, Holom GH, Amayu KN.

Health Econ Policy Law. 2018 Jan;13(1):50-67. doi: 10.1017/S1744133117000019. Epub 2017 Apr 6.

PMID:
28382886
20.

The health policy pendulum: Cost control vs activity growth.

Tjerbo T, Hagen TP.

Int J Health Plann Manage. 2018 Jan;33(1):e67-e75. doi: 10.1002/hpm.2407. Epub 2017 Mar 20.

PMID:
28317168
21.

Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.

George A, Kristeleit R, Rafii S, Michie CO, Bowen R, Michalarea V, van Hagen T, Wong M, Rallis G, Molife LR, Lopez J, Banerji U, Banerjee SN, Gore ME, de Bono JS, Kaye SB, Yap TA.

Eur J Cancer. 2017 May;76:52-59. doi: 10.1016/j.ejca.2017.01.020. Epub 2017 Mar 6.

PMID:
28273485
22.

Activation of MAPK/ERK signaling by Burkholderia pseudomallei cycle inhibiting factor (Cif).

Ng MY, Wang M, Casey PJ, Gan YH, Hagen T.

PLoS One. 2017 Feb 6;12(2):e0171464. doi: 10.1371/journal.pone.0171464. eCollection 2017.

23.

Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.

Helgren TR, Chen C, Wangtrakuldee P, Edwards TE, Staker BL, Abendroth J, Sankaran B, Housley NA, Myler PJ, Audia JP, Horn JR, Hagen TJ.

Bioorg Med Chem. 2017 Feb 1;25(3):813-824. doi: 10.1016/j.bmc.2016.11.013. Epub 2016 Nov 10.

24.

Assessing physician productivity following Norwegian hospital reform: A panel and data envelopment analysis.

Johannessen KA, Kittelsen SA, Hagen TP.

Soc Sci Med. 2017 Feb;175:117-126. doi: 10.1016/j.socscimed.2017.01.008. Epub 2017 Jan 6.

PMID:
28088617
25.

Inhomogeneous crystal grain formation in DPPC-DSPC based thermosensitive liposomes determines content release kinetics.

Lu T, Ten Hagen TLM.

J Control Release. 2017 Feb 10;247:64-72. doi: 10.1016/j.jconrel.2016.12.030. Epub 2016 Dec 29.

26.

The Role of Mitochondrial Non-Enzymatic Protein Acylation in Ageing.

Hong SY, Ng LT, Ng LF, Inoue T, Tolwinski NS, Hagen T, Gruber J.

PLoS One. 2016 Dec 29;11(12):e0168752. doi: 10.1371/journal.pone.0168752. eCollection 2016.

27.

Reinventing the community hospital: a retrospective population-based cohort study of a natural experiment using register data.

Swanson JO, Hagen TP.

BMJ Open. 2016 Dec 13;6(12):e012892. doi: 10.1136/bmjopen-2016-012892.

28.

Cell membrane modulation as adjuvant in cancer therapy.

Zalba S, Ten Hagen TL.

Cancer Treat Rev. 2017 Jan;52:48-57. doi: 10.1016/j.ctrv.2016.10.008. Epub 2016 Nov 9. Review.

29.

High-Resolution Intravital Microscopy of Tumor Angiogenesis.

Seynhaeve AL, Ten Hagen TL.

Methods Mol Biol. 2016;1464:115-127.

PMID:
27858361
30.

Melanomas prevent endothelial cell death under restrictive culture conditions by signaling through AKT and p38 MAPK/ ERK-1/2 cascades.

Das AM, Pescatori M, Vermeulen CE, Rens JA, Seynhaeve AL, Koning GA, Eggermont AM, Ten Hagen TL.

Oncoimmunology. 2016 Aug 12;5(10):e1219826. eCollection 2016.

31.

Major involvement of trunk muscles in myotonic dystrophy type 1.

Solbakken G, Ørstavik K, Hagen T, Dietrichs E, Naerland T.

Acta Neurol Scand. 2016 Dec;134(6):467-473. doi: 10.1111/ane.12565. Epub 2016 Feb 1.

PMID:
26984572
32.

Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.

Hoekstra E, Das AM, Willemsen M, Swets M, Kuppen PJ, van der Woude CJ, Bruno MJ, Shah JP, Ten Hagen TL, Chisholm JD, Kerr WG, Peppelenbosch MP, Fuhler GM.

Oncotarget. 2016 Nov 8;7(45):73525-73540. doi: 10.18632/oncotarget.12321.

33.

Glutathione maintenance mitigates age-related susceptibility to redox cycling agents.

Thomas NO, Shay KP, Kelley AR, Butler JA, Hagen TM.

Redox Biol. 2016 Dec;10:45-52. doi: 10.1016/j.redox.2016.09.010. Epub 2016 Sep 22.

34.

Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration.

Das AM, Bolkestein M, van der Klok T, Oude Ophuis CM, Vermeulen CE, Rens JA, Dinjens WN, Atmodimedjo PN, Verhoef C, Koljenović S, Smits R, Ten Hagen TL, Eggermont AM.

Eur J Cancer. 2016 Oct;66:34-46. doi: 10.1016/j.ejca.2016.06.020. Epub 2016 Aug 11.

PMID:
27522248
35.

Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.

Lokerse WJ, Bolkestein M, Ten Hagen TL, de Jong M, Eggermont AM, Grüll H, Koning GA.

Theranostics. 2016 Jun 24;6(10):1717-31. doi: 10.7150/thno.14960. eCollection 2016.

36.

EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery.

Haeri A, Zalba S, Ten Hagen TL, Dadashzadeh S, Koning GA.

Colloids Surf B Biointerfaces. 2016 Oct 1;146:657-69. doi: 10.1016/j.colsurfb.2016.06.012. Epub 2016 Jun 11.

PMID:
27434152
37.

The Change Detection Advantage for Animals: An Effect of Ancestral Priorities or Progeny of Experimental Design?

Hagen T, Laeng B.

Iperception. 2016 Jun 27;7(3):2041669516651366. doi: 10.1177/2041669516651366. eCollection 2016 May.

38.

A Novel Combined Approach of Short-Chain Sphingolipids and Thermosensitive Liposomes for Improved Drug Delivery to Tumor Cells.

Haeri A, Pedrosa LR, Ten Hagen TL, Dadashzadeh S, Koning GA.

J Biomed Nanotechnol. 2016 Apr;12(4):630-44.

PMID:
27301190
39.

Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.

Mishra V, Fiane AE, Winsnes BA, Geiran O, Sørensen G, Hagen TP, Gude E.

Scand Cardiovasc J. 2017 Feb;51(1):1-7. doi: 10.1080/14017431.2016.1196826. Epub 2016 Jun 20.

PMID:
27248460
40.

T.P. Hagen og medarbeidere svarer.

Hagen TP, Iversen T, Moger TA.

Tidsskr Nor Laegeforen. 2016 May 3;136(8):690. doi: 10.4045/tidsskr.16.0331. eCollection 2016 May. Norwegian. No abstract available.

PMID:
27143451
Free Article
41.

C. elegans miro-1 Mutation Reduces the Amount of Mitochondria and Extends Life Span.

Shen Y, Ng LF, Low NP, Hagen T, Gruber J, Inoue T.

PLoS One. 2016 Apr 11;11(4):e0153233. doi: 10.1371/journal.pone.0153233. eCollection 2016.

42.

Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.

Saeed M, van Brakel M, Zalba S, Schooten E, Rens JA, Koning GA, Debets R, Ten Hagen TL.

Int J Nanomedicine. 2016 Mar 8;11:955-75. doi: 10.2147/IJN.S96123. eCollection 2016.

43.

Risk adjustment in measurements of predicted mortality after myocardial infarction.

Hagen TP, Iversen T, Moger TA.

Tidsskr Nor Laegeforen. 2016 Mar 15;136(5):423-7. doi: 10.4045/tidsskr.13.1292. eCollection 2016 Mar 15. English, Norwegian.

44.

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome.

Hoekstra E, Das AM, Swets M, Cao W, van der Woude CJ, Bruno MJ, Peppelenbosch MP, Kuppen PJ, Ten Hagen TL, Fuhler GM.

Oncotarget. 2016 Apr 19;7(16):21922-38. doi: 10.18632/oncotarget.7829.

45.

Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin.

de Bruijn HS, Brooks S, van der Ploeg-van den Heuvel A, Ten Hagen TL, de Haas ER, Robinson DJ.

PLoS One. 2016 Feb 12;11(2):e0148850. doi: 10.1371/journal.pone.0148850. eCollection 2016.

46.

Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.

Hong SY, Yu FX, Luo Y, Hagen T.

Cell Signal. 2016 May;28(5):377-383. doi: 10.1016/j.cellsig.2016.01.011. Epub 2016 Jan 28.

PMID:
26826652
47.

In depth study on thermosensitive liposomes: Optimizing formulations for tumor specific therapy and in vitro to in vivo relations.

Lokerse WJ, Kneepkens EC, ten Hagen TL, Eggermont AM, Grüll H, Koning GA.

Biomaterials. 2016 Mar;82:138-50. doi: 10.1016/j.biomaterials.2015.12.023. Epub 2015 Dec 22.

PMID:
26761778
48.

Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.

Das AM, Koljenović S, Oude Ophuis CM, van der Klok T, Galjart B, Nigg AL, van Cappellen WA, Noordhoek Hegt V, Dinjens WN, Atmodimedjo PN, Vermeulen CE, Verhoef C, Eggermont AM, ten Hagen TL.

Eur J Cancer. 2016 Jan;53:135-43. doi: 10.1016/j.ejca.2015.09.014. Epub 2015 Dec 17.

PMID:
26707830
49.

Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.

Willerding L, Limmer S, Hossann M, Zengerle A, Wachholz K, Ten Hagen TL, Koning GA, Sroka R, Lindner LH, Peller M.

J Control Release. 2016 Jan 28;222:47-55. doi: 10.1016/j.jconrel.2015.12.004. Epub 2015 Dec 3.

PMID:
26658073
50.

Elephantiasis nostras verrucosa

Hagen TL.

Ugeskr Laeger. 2015 Dec 7;177(50):V66925. Danish. No abstract available.

PMID:
26651909

Supplemental Content

Support Center